Patrick Leavey, M.D. Titles and Appointments Associate Vice Chair of Research Operations Professor Schools Medical School Departments Pediatrics You have reached the Academic Profile. For more information on the doctor and patient care, please visit the clinical profile. Biography Patrick Leavey graduated from the Royal College of Surgeons in Ireland in 1986. He spent 4 years in Ireland as a junior house officer (Internal Medicine and Pediatrics), 2 years at Princess Margaret Hospital in Perth, Western Australia as a pediatric registrar and then came to the US to do his pediatric hematology/oncology fellowship at The Children’s Hospital Denver and University of Colorado Health Sciences Center in 1992. Dr. Leavey worked in the lab of Daniel Ambruso, M.D. for 4 years on projects related to the influence of G-CSF on granulocyte function and the exploration and identification of a novel neutrophil cytosolic protein. Dr. Leavey joined the pediatric faculty at UT Southwestern Medical Center in 1998 where he is currently a Professor of Pediatrics and a Pediatric Oncologist at Children’s Health, Children’s Medical Center Dallas and Plano. During his years of training Dr. Leavey became a member of the Royal College of Physicians of Ireland, a Fellow of the Royal Australasian College of Physicians and a Diplomate of Child Health from the National University of Ireland. He was granted a Doctorate in Medicine from the National University of Ireland, based on his work in the Ambruso laboratory. He is subspecialty board certified in Pediatric Hematology/Oncology by the American Board of Pediatrics. Currently Dr. Leavey holds several leadership positions both regionally and nationally. He is the Associate Vice Chair for Research Operations at the Department of Pediatrics, and the Associate Director for Clinical research for the Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center Dallas. Dr. Leavey is the Immediate Past President of the Active Medical / Dental Staff at Children's Medical Center Dallas and past President of the American Society of Pediatric Hematology/Oncology. At the Children’s Oncology Group (COG), Dr. Leavey was a long-standing member of the Bone Sarcoma Steering Committee up to 2023. Dr. Leavey continues to serve on medical advisory boards for the Children’s Cancer Fund and The Clayton Dabney Foundation. Dr. Leavey hold several key positions in clinical and translational research. He is the co-chair for the COG study AOST2031, a co-investigator for a CPRIT funded study of whole slide imaging in pediatric rhabdomyosarcoma and the principal investigator for a Team Connor Foundation award to study machine learning tools in osteosarcoma. Dr. Leavey is also the site PI for an American Society of Hematology Award, establishing the North Texas Sickle Cell Disease Clinical Trial Unit. Education Medical School Royal College of Surgeons (1986) Internship Beaumont Hospital (1987), General Surgery Residency St. Vincents Hospital - Dublin Ireland (1989), Internal Medicine Fellowship University of Colorado Health Sciences Center (1996), Pediatric Hematology/oncology Residency Children's Hospital of Denver (1998), Pediatrics Research Interest Development of advances in therapy for children with sarcoma Development of novel biomarkers for patients with bone and soft tissue sarcoma using advanced imaging, digital histology and automated learning tools Publications Molecular Characterization Informs Prognosis in Patients With Localized Ewing Sarcoma: A Report From the Children's Oncology Group Gillani R, Shulman DS, DelRocco NJ, Klega K, Han R, Krailo MD, Slack JC, Tanhaemami M, Ward A, Bainer V, Ricker C, Sparks J, Bailey KM, Reed DR, DuBois SG, Leavey P, Mascarenhas L, Grohar PJ, Church AJ, Crompton BD, Janeway KA Journal of Clinical Oncology 2025 Dec 43 3750-3759 Preoperative Radiotherapy in Patients With Localized Ewing Sarcoma Enrolled on AEWS1031: A Report From the Children's Oncology Group Indelicato DJ, Callan AK, Ahmed SK, Krailo M, DelRocco N, Buxton AB, Binitie OT, Christ AB, Kessell S, Chuba PJ, Nadel HR, Pawel BR, Gorlick R, Reed DR, DuBois SG, Janeway KA, Leavey P, Mascarenhas L, Laack NN Pediatric Blood and Cancer 2025 Aug 72 Factors Associated With Primary Site Local Therapy in Patients With Nonmetastatic Ewing Sarcoma Treated With Interval-Compressed Chemotherapy: A Report From the Children’s Oncology Group Ahmed SK, Binitie O, Krailo M, Indelicato DJ, Callan AK, DelRocco N, Buxton A, Chuba P, Christ A, Randall RL, Nadel H, Pawel B, Reed DR, Gorlick RG, DuBois SG, Janeway KA, Leavey PJ, Mascarenhas L, Laack NN International Journal of Radiation Oncology Biology Physics 2025 125 521-529 COVID-19 mRNA vaccination responses in individuals with sickle cell disease: An ASH RC Sickle Cell Research Network Study Anderson AR, Strouse JJ, Manwani D, Brandow AM, Vichinsky E, Campbell A, Leavey PJ, Nero A, Ibrahim IF, Field JJ, Baer A, Soto-Calderon H, Vincent L, Zhao Y, Santos JJ, Hensley SE, Mortier N, Lanzkron S, Neuberg D, Abrams CS, Andemariam B, Brandow A, Cohen A, Darbari D, Rassi FE, Field J, Fung E, Gee B, Ibrahim I, Idowu M, Kanter J, Klings ES, King A, Kutlar A, Lebensburger JD, Leavey P, Liem RI, Narang S, Pace B, Quinn CT, Rivlin K, Thompson AA, Tubman VN, Walters M Blood Advances 2024 Sep 8 4549-4553 Machine Learning for Rhabdomyosarcoma Whole Slide Images Sub-type Classification Yadav A, Daescu O, Leavey P, Rudzinski E 2023 Jul 192-196 Osteosarcoma Explorer: A Data Commons With Clinical, Genomic, Protein, and Tissue Imaging Data for Osteosarcoma Research Yang DM, Zhou Q, Furman-Cline L, Cheng X, Luo D, Lai H, Li Y, Jin KW, Yao B, Leavey PJ, Rakheja D, Lo T, Hall D, Barkauskas DA, Shulman DS, Janeway K, Khanna C, Gorlick R, Menzies C, Zhan X, Xiao G, Skapek SX, Xu L, Klesse LJ, Crompton BD, Xie Y JCO Clinical Cancer Informatics 2023 7 An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma Shulman DS, Whittle SB, Surdez D, Bailey KM, de Álava E, Yustein JT, Shlien A, Hayashi M, Bishop AJ, Crompton BD, DuBois SG, Shukla N, Leavey PJ, Lessnick SL, Kovar H, Delattre O, Grünewald TG, Antonescu CR, Roberts RD, Toretsky JA, Tirode F, Gorlick R, Janeway KA, Reed D, Lawlor ER, Grohar PJ npj Precision Oncology 2022 Dec 6 Enhancing access to and diversity in cancer clinical trials through a financial reimbursement program: Protocol to evaluate a novel program Gerber DE, Tiro JA, McNeill LH, Williams EL, Zhu H, Lee SJ, Leavey PJ, Sadeghi N, Kapinos KA, Dornsife DL, Nguyen V, Wileyto EP, Guerra CE Contemporary Clinical Trials 2022 Oct 121 Deep Learning of Rhabdomyosarcoma Pathology Images for Classification and Survival Outcome Prediction Zhang X, Wang S, Rudzinski ER, Agarwal S, Rong R, Barkauskas DA, Daescu O, Furman Cline L, Venkatramani R, Xie Y, Xiao G, Leavey P American Journal of Pathology 2022 Jun 192 917-925 Reply to J.-G. Wang et al Leavey PJ, Krailo MD, Dubois SG, Reed DR, Janeway KA, Mascarenhas L Journal of Clinical Oncology 2022 May 40 1507-1508 Results 1-10 of 72 1 2 3 4 5 Next Last Books Featured Books Histopathological Diagnosis for Viable and Non-viable Tumor Prediction for Osteosarcoma Using Convolutional Neural Network. In Bioinformatics Research and Verlag Mishra R, Daescu O, Leavey P, Rakheja D, Sengupta A. (2017). Springer Honors & Awards UT Southwestern Annual Leaders in Clinical Excellence, Program Development Award (nominee) (2021-2022) DFWHC Foundation, Dallas Physician of the Year (nominee)Sponsored by Children's Health, Children's Medical Center Dallas (2020) Physician of the YearChildren's Health, Children's Medical Center Dallas (2020) Best Pediatric Specialists/Doctors in DallasD Magazine (2010-2023) Faculty Teaching AwardUT Southwestern and Children's Medical Center (2009) Medical Achievement AwardLittle Mo Award - awarded by Wipe out Kids Cancer (2008) Elected to the Society for Pediatric Research (2006) Achievement AwardGift of Giving Back Award; first such award given by the Clayton Dabney Foundation for Kids with Cancer (2005) Professional Associations/Affiliations American Society of Clinical Oncology (2012) American Society of Pediatric Hematology/Oncology (2004) Children's Oncology Group (2002) Connective Tissue Oncology Society Dallas County Medical Society and Texas Medical Association Society for Pediatric Research (2006)
